Eosinophilic Airway Inflammation
Eosinophilic Airway Inflammation - Related Videos
07:52
Analysis of Pulmonary Dendritic Cell Maturation and Migration during Allergic Airway Inflammation
0 Views •
Cited by 1 •
2012
We describe a strategy to monitor maturation and migration of pulmonary dendritic cells in response to ovalbumin in the setting of ovalbumin induced allergic airway inflammation. This strategy can be modified to assess migration of pulmonary dendritic cells in settings of infection.
09:56
Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
0 Views •
Cited by 2 •
2016
We demonstrate the procedure for intra-tracheal inoculation of Haemophilus influenzae into the lower respiratory tracts of mice. This is a very useful tool to study signaling pathways that regulate airway inflammation in mouse models.
04:33
Methods for Detecting Cough and Airway Inflammation in Mice
0 Views •
Cited by 1 •
2024
Here, we describe the measurement of cough using a noninvasive and real-time whole-body plethysmography (WBP) system and the normative procedures for harvesting tissue samples of mice and introduce some methods to assess airway inflammation.
08:44
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
0 Views •
2020
Environmental allergens such as house dust mites (HDM) often contain microbial substances that activate innate immune responses to regulate allergic inflammation. The protocol presented here demonstrates the identification of dsRNA species in HDM allergens and characterization of their immunogenic activities in modulating eosinophilic lung inflammation.
01:38
Inflammation
0 Views •
2019
Overview In response to tissue injury and infection, mast cells initiate inflammation. Mast cells release chemicals that increase the permeability of adjacent blood capillaries and attract additional immune cells to the wound or site of infection. Neutrophils are phagocytic leukocytes that exit the bloodstream and engulf invading microbes. Blood clotting platelets seal the wound and fibers create a scaffold for wound healing. Macrophages engulf aging neutrophils to end the acute inflammatory...
FAQs
Interleukin-5 acts as a type 2 inflammatory signal that promotes eosinophil migration into airway tissues. Once recruited, these cells release cytotoxic granules and other mediators, linking the immune response to local airway injury and dysfunction. This mechanism helps explain why type 2 signaling is an important consideration when characterizing inflammatory patterns in respiratory disease.
Eosinophil-derived cytotoxic granules and other mediators can injure the airway epithelium, the tissue lining the respiratory tract. They may also promote mucus production and airway hyperresponsiveness, meaning an exaggerated tendency of the airways to react. Together, these effects can contribute to impaired airway function and help explain symptoms in some inflammatory airway diseases.
Recognizing an eosinophilic pattern helps characterize asthma phenotypes rather than treating all airway inflammation as biologically identical. This information can support decisions about corticosteroid or biologic therapy and may improve assessment of disease severity, exacerbation risk, and likely treatment response. The pattern therefore adds clinically useful information beyond respiratory symptoms alone.
Blood or sputum eosinophil counts provide ways to identify this inflammatory pattern. Blood testing samples circulating eosinophils, whereas sputum assessment reflects eosinophils present in respiratory secretions. These measurements help characterize disease in clinical or research settings and can provide information used to guide treatment decisions, although the overview does not specify particular collection thresholds or laboratory procedures.
The presence of an eosinophilic pattern can support targeted consideration of corticosteroids and biologic therapies, particularly when clinicians are evaluating asthma phenotype and treatment response. These therapies are relevant because the inflammatory process is linked to type 2 signals and eosinophil activity. The assessment can therefore help align treatment selection with the patient's underlying inflammatory characteristics.
Studying this process can improve understanding of asthma severity, the risk of exacerbations, and how a patient may respond to treatment. Eosinophil counts in blood or sputum contribute to that assessment by identifying an inflammatory phenotype. In medicine, this information supports a more targeted interpretation of disease behavior and can help evaluate whether treatment is addressing the relevant inflammatory pattern.